Residual tumour less than 0.25 centimetres and positive lymph nodes are risk factors for early relapse in recurrent ovarian peritoneal carcinomatosis treated with cytoreductive surgery, HIPEC and systemic chemotherapy-Reference-Cited by-同舟云学术

Residual tumour less than 0.25 centimetres and positive lymph nodes are risk factors for early relapse in recurrent ovarian peritoneal carcinomatosis treated with cytoreductive surgery, HIPEC and systemic chemotherapy

Published:2018-01-17 Issue:5 Volume:34 Page:570-577
ISSN:0265-6736
Container-title:International Journal of Hyperthermia
language:en
Short-container-title:International Journal of Hyperthermia

Author:

Arjona-Sanchez Alvaro¹²,Rufian-Peña Sebastian¹²,Artiles Manuel¹,Sánchez-Hidalgo Juan Manuel¹²,Casado-Adam Ángela¹²,Cosano Antonio¹,Thoelecke Heather¹,Ramnarine Sharmila¹,Garcilazo Dimas¹,Briceño-Delgado Javier¹²

Affiliation:

1. Oncologic and Pancreatic Surgery Unit, University Hospital Reina Sofía, Córdoba, Spain;

2. Maimonides Biomedical Research Institute of Córdoba (IMIBIC), University Hospital Reina Sofía, University of Córdoba, Córdoba, Spain

Publisher

Informa UK Limited

Subject

Cancer Research,Physiology (medical),Physiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02656736.2018.1423708

Reference25 articles.

1. Cancer Statistics, 2007

2. Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals